Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Generic Sovaldi makers could pocket upwards of $600m says analyst
Generic Sovaldi makers could pocket upwards of $600m says analyst
Generic Sovaldi makers could pocket upwards of $600m says analyst
Submitted by
admin
on September 25, 2014 - 9:25am
Source:
In-Pharma Technologist
News Tags:
generics
Sovaldi
Gilead Sciences
hepatitis C
Mylan
Strides Arcolab
Cadila
Cipla
Hetero Labs
Ranbaxy
Sequent Scientific
Headline:
Generic Sovaldi makers could pocket upwards of $600m says analyst
Do Not Allow Advertisers to Use My Personal information
